New predictive software integrated into an insulin pump can reduce time spent in hypoglycaemia compared with sensor-augmented pumps in type 1 disease. Medical device firm Tandem Diabetes Care has ...
Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care to integrate (AID) data.
(Nasdaq: TNDM) a leading insulin delivery and diabetes technology company, today announced availability of the Tandem t:slim mobile application for Android and iOS users in Canada. The Tandem t:slim ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated ...
When the skies open and power lines go down, a reliable backup sump pump could be the difference between a dry basement and thousands of dollars in damage (along with a big headache). And because ...
While not exactly a necessity for nursing mothers, breast pumps can certainly ease the challenge, particularly for those balancing work and motherhood. They serve as an excellent tool to guarantee ...
Danfoss Power Solutions announces the launch of its MP1T axial piston tandem pump. An addition to the company’s popular MP1 medium-power closed-circuit hydraulic platform, the MP1T tandem pump offers ...
Danfoss Power Solutions has launched its MP1T axial piston tandem pump. An addition to the company’s popular MP1 medium-power closed-circuit hydraulic platform, the MP1T tandem pump offers high ...
According to Danfoss, the MP1T offers market-leading total efficiency, lowering overall ownership costs. Its field-proven rotating kit, also used in other MP1 products, delivers up to 6% higher ...
Tandem Diabetes has issued a voluntary correction for its t:slim X2 insulin pumps following confirmed adverse events due to a dangerous error. The error will ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker ...
(MENAFN- GlobeNewsWire - Nasdaq) The global insulin pump market, valued at USD 4.31 billion in 2024, is projected to soar to USD 7.27 billion by 2030 with a CAGR of 9.10% due to rising diabetes cases ...